Endocrine Testing Market 2022-2027: Report, Industry Size, Share, Growth Factors and Business Opportunities
Endocrine testing assists in detecting a hormonal imbalance in the body, which may lead to the development of different chronic conditions.
According to the latest report by IMARC Group, titled “Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on endocrine testing market share. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global endocrine testing market size reached US$ 9.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 15.3 Billion by 2027, exhibiting a growth rate (CAGR) of 8.08% during 2022-2027.
Endocrine testing refers to the medical procedure conducted to measure the level of hormones produced by the endocrine glands in the human body. It helps in diagnosing hormonal disorders and planning the best course of treatment. It can interpret a variety of hormonal diseases, including parathyroid neuroendocrine tumors, carcinoid tumors, and others.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/endocrine-testing-market/requestsample
The global market is majorly driven by the increasing prevalence of endocrine-related disorders such as diabetes, hypogonadism, hypergonadism, and conditions related to the thyroid and adrenal glands. In line with this, the growing geriatric population, coupled with rising awareness about early diagnosis and treatment, is positively influencing the market growth across the globe. Furthermore, rapid advancements in product technologies and the rising affordability of healthcare services are significantly contributing to the market growth. Besides this, increasing health awareness among individuals is catalyzing the market growth. Moreover, the introduction of easy-to-operate testing kits facilitating home-based diagnosis is creating a positive market outlook.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/endocrine-testing-market
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- BioMerieux SA
- DiaSorin S.p.A.
- Hoffmann-La Roche AG (Roche Holding AG)
- Laboratory Corporation of America Holdings
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc
Global Endocrine Testing Market Segmentation:
Our report has categorized the market based on region, test type, technology and end-use.
By Test Type:
- Thyroid Test
- Insulin Test
- Human Chorionic Gonadotropin Test
- Prolactin Test
- Luteinizing Hormone Test
- Progesterone Test
- Tandem Mass Spectroscopy
- Sensor Technology
By End Use:
- Ambulatory Care Centers
- Clinical Laboratories
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800